Effect of Bariatric Surgery on Hypertension: A Meta-analysis

Annals of Pharmacotherapy

Volumn 48, Issue 6, 2014, Pages 674-682

  Wilhelm, Sheila M ^a,b   Young, Jamie ^a   Kale Pradhan, Pramodini B ^a,c  

^a WAYNE STATE UNIVERSITY   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

^c ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

bariatric; hypertension; obesity; surgery

Indexed keywords

ARTICLE; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; FOLLOW UP; GASTRIC BANDING; HUMAN; HYPERTENSION; META ANALYSIS; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; SYSTEMATIC REVIEW; ADULT;

ADULT; BARIATRIC SURGERY; HUMANS; HYPERTENSION; OBESITY;

EID: 84899741428     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028014529260     Document Type: Article

References (69)

1. OgdenCLCarrollMDKitBKFlegalKM. Prevalence of obesity in the United States, 2009-2010. http://www.cdc.gov/nchs/data/databriefs/db82.pdf. Accessed January 31, 2014.
2. National Institutes of Health National Heart, Lung and Blood Institute, North American Associaton for the Study of Obesity. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. http://www.nhlbi.nih.gov/guidelines/obesity/prctgd_c.pdf. Accessed January 31, 2014.
3. Elder KA,Wolfe BM.Bariatric surgery: a review of procedures and outcomes.Gastroenterology. 2007;132:2253-2271.
4. Samuel I,Mason EE,Renquist KE,Huang YH,Zimmerman MB,Jamal M.Bariatric surgery trends: an 18-year report from the International Bariatric Surgery Registry.Am J Surg. 2006;192:657-662.
5. National Institutes of Health National Heart, Lung and Blood Institute. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: the evidence report. http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf. Accessed January 31, 2014.
6. FreidVMBernsteinABBushMA. Multiple chronic conditions among adults aged 45 and over: trends over the past 10 years. NCHS Data Brief 2012:1-8. http://www.cdc.gov/nchs/data/databriefs/db100.pdf (accessed March 16, 2014).
7. Buchwald H,Estok R,Fahrbach K,et al.Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis.Am J Med. 2009;122:248-256.e5.
8. Moher D,Liberati A,Tetzlaff J,Altman DG,Group P.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.PLoS Med. 2009;6:e1000097.
9. HigginsJPGreenS, eds. Cochrane handbook for systematic reviews of interventions 5.0.http://www.cochrane-handbook.orgAccessed January 31, 2014.
10. Review Manager (RevMan) [computer program]. Version 5.2. http://ims.cochrane.org/revman. Accessed January 31, 2014.
11. Foley EF,Benotti PN,Borlase BC,Hollingshead J,Blackburn GL.Impact of gastric restrictive surgery on hypertension in the morbidly obese.Am J Surg. 1992;163:294-297.
12. Carson JL,Ruddy ME,Duff AE,Holmes NJ,Cody RP,Brolin RE.The effect of gastric bypass surgery on hypertension in morbidly obese patients.Arch Intern Med. 1994;154:193-200.
13. Cowan GS,Buffington CK.Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery.World J Surg. 1998;22:987-992.
14. Scopinaro N,Adami GF,Marinari GM,et al.Biliopancreatic diversion.World J Surg. 1998;22:936-946.
15. Bacci V,Basso MS,Greco F,et al.Modifications of metabolic and cardiovascular risk factors after weight loss induced by laparoscopic gastric banding.Obes Surg. 2002;12:77-82.
16. Papasavas PK,Hayetian FD,Caushaj PF,et al.Outcome analysis of laparoscopic Roux-en-Y gastric bypass for morbid obesity: the first 116 cases.Surg Endosc. 2002;16:1653-1657.
17. Sugerman HJ,Wolfe LG,Sica DA,Clore JN.Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss.Ann Surg. 2003;237:751-756.
18. Busetto L,Sergi G,Enzi G,et al.Short-term effects of weight loss on the cardiovascular risk factors in morbidly obese patients.Obes Res. 2004;12:1256-1263.
19. Frigg A,Peterli R,Peters T,Ackermann C,Tondelli P.Reduction in co-morbidities 4 years after laparoscopic adjustable gastric banding.Obes Surg. 2004;14:216-23.
20. Ponce J,Haynes B,Paynter S,et al.Effect of Lap-Band-induced weight loss on type 2 diabetes mellitus and hypertension.Obes Surg. 2004;14:1335-1342.
21. Spivak H,Anwar F,Burton S,Guerrero C,Onn A.The Lap-Band system in the United States: one surgeon's experience with 271 patients.Surg Endosc. 2004;18:198-202.
22. Adami GF,Papadia F,Carlini F,Murelli F,Scopinaro N.Effect of biliopancreatic diversion on hypertension in severely obese patients.Hypertens Res. 2005;28:119-123.
23. Ahroni JH,Montgomery KF,Watkins BM.Laparoscopic adjustable gastric banding: weight loss, co-morbidities, medication usage and quality of life at one year.Obes Surg. 2005;15:641-647.
24. Obeid F,Falvo A,Dabideen H,Stocks J,Moore M,Wright M.Open Roux-en-Y gastric bypass in 925 patients without mortality.Am J Surg. 2005;189:352-356.
25. White S,Brooks E,Jurikova L,Stubbs RS.Long-term outcomes after gastric bypass.Obes Surg. 2005;15:155-163.
26. Bowne WB,Julliard K,Castro AE,Shah P,Morgenthal CB,Ferzli GS.Laparoscopic gastric bypass is superior to adjustable gastric band in super morbidly obese patients: A prospective, comparative analysis.Arch Surg. 2006;141:683-689.
27. Cottam DR,Atkinson J,Anderson A,Grace B,Fisher B.A case-controlled matched-pair cohort study of laparoscopic Roux-en-Y gastric bypass and Lap-Band patients in a single US center with three-year follow-up.Obes Surg. 2006;16:534-540.
28. Puzziferri N,Austrheim-Smith IT,Wolfe BM,Wilson SE,Nguyen NT.Three-year follow-up of a prospective randomized trial comparing laparoscopic versus open gastric bypass.Ann Surg. 2006;243:181-188.
29. Serra A,Granada ML,Romero R,et al.The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up.Clin Nutr. 2006;25:400-408.
30. Alexandrides TK,Skroubis G,Kalfarentzos F.Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity.Obes Surg. 2007;17:176-184.
31. Batsis JA,Romero-Corral A,Collazo-Clavell ML,et al.Effect of weight loss on predicted cardiovascular risk: change in cardiac risk after bariatric surgery.Obesity. 2007;15:772-784.
32. Goergen M,Arapis K,Limgba A,Schiltz M,Lens V,Azagra JS.Laparoscopic Roux-en-Y gastric bypass versus laparoscopic vertical banded gastroplasty: results of a 2-year follow-up study.Surg Endosc. 2007;21:659-664.
33. Larrad-Jimenez A,Diaz-Guerra CS,de Cuadros Borrajo P,Lesmes IB,Esteban BM.Short-, mid- and long-term results of Larrad biliopancreatic diversion.Obes Surg. 2007;17:202-210.
34. Paran H,Shargian L,Shwartz I,Gutman M.Long-term follow-up on the effect of silastic ring vertical gastroplasty on weight and co-morbidities.Obes Surg. 2007;17:737-741.
35. Peluso L,Vanek VW.Efficacy of gastric bypass in the treatment of obesity-related comorbidities.Nutr Clin Pract. 2007;22:22-28.
36. Vogel JA,Franklin BA,Zalesin KC,et al.Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery.Am J Cardiol. 2007;99:222-226.
37. Brancatisano A,Wahlroos S,Brancatisano R.Improvement in comorbid illness after placement of the Swedish Adjustable Gastric Band.Surg Obes Relat Dis. 2008;4:S39-S46.
38. Busetto L,Angrisani L,Basso N,et al.Safety and efficacy of laparoscopic adjustable gastric banding in the elderly.Obesity. 2008;16:334-338.
39. Khalaileh A,Matot I,Schweiger C,Appelbaum L,Elazary R,Keidar A.Laparoscopic Roux-en-Y gastric bypass for the treatment of morbid obesity: experience with 50 patients.Isr Med Assoc J. 2008;10:350-353.
40. Kligman MD,Dexter DJ,Omer S,Park AE.Shrinking cardiovascular risk through bariatric surgery: application of Framingham risk score in gastric bypass.Surgery. 2008;143:533-538.
41. Maher JW,Martin Hawver L,Pucci A,Wolfe LG,Meador JG,Kellum JM.Four hundred fifty consecutive laparoscopic Roux-en-Y gastric bypasses with no mortality and declining leak rates and lengths of stay in a bariatric training program.J Am Coll Surg. 2008;206:940-944.
42. Muller MK,Rader S,Wildi S,Hauser R,Clavien PA,Weber M.Long-term follow-up of proximal versus distal laparoscopic gastric bypass for morbid obesity.Br J Surg. 2008;95:1375-1379.
43. Pinheiro JS,Schiavon CA,Pereira PB,Correa JL,Noujaim P,Cohen R.Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients.Surg Obes Relat Dis. 2008;4:521-525.
44. Sears D,Fillmore G,Bui M,Rodriguez J.Evaluation of gastric bypass patients 1 year after surgery: changes in quality of life and obesity-related conditions.Obes Surg. 2008;18:1522-1525.
45. Singhal R,Kitchen M,Bridgwater S,Super P.Metabolic outcomes of obese diabetic patients following laparoscopic adjustable gastric banding.Obes Surg. 2008;18:1400-1405.
46. Yan E,Ko E,Luong V,Wang HJ,Romanova M,Li Z.Long-term changes in weight loss and obesity-related comorbidities after Roux-en-Y gastric bypass: a primary care experience.Am J Surg. 2008;195:94-98.
47. Ahmed AR,Rickards G,Coniglio D,et al.Laparoscopic Roux-en-Y gastric bypass and its early effect on blood pressure.Obes Surg. 2009;19:845-849.
48. Csendes A,Maluenda F,Burgos AM.A prospective randomized study comparing patients with morbid obesity submitted to laparotomic gastric bypass with or without omentectomy.Obes Surg. 2009;19:490-494.
49. Pontiroli AE,Laneri M,Veronelli A,et al.Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters.Cardiovasc Diabetol. 2009;8:37.
50. Steffen R,Potoczna N,Bieri N,Horber FF.Successful multi-intervention treatment of severe obesity: a 7-year prospective study with 96% follow-up.Obes Surg. 2009;19:3-12.
51. Sultan S,Parikh M,Youn H,Kurian M,Fielding G,Ren C.Early U.S. outcomes after laparoscopic adjustable gastric banding in patients with a body mass index less than 35 kg/m2.Surg Endosc. 2009;23:1569-1573.
52. Bueter M,Dubb SS,Gill A,et al.Renal cytokines improve early after bariatric surgery.Br J Surg. 2010;97:1838-1844.
53. Hofso D,Nordstrand N,Johnson LK,et al.Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention.Eur J Endocrinol. 2010;163:735-745.
54. Prachand VN,Ward M,Alverdy JC.Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI > or = 50 kg/m2) compared with gastric bypass.J Gastrointest Surg. 2010;14:211-220.
55. Schouten R,Wiryasaputra DC,van Dielen FM,van Gemert WG,Greve JW.Long-term results of bariatric restrictive procedures: a prospective study.Obes Surg. 2010;20:1617-1626.
56. Benaiges D,Goday A,Ramon JM,et al.Laparoscopic sleeve gastrectomy and laparoscopic gastric bypass are equally effective for reduction of cardiovascular risk in severely obese patients at one year of follow-up.Surg Obes Relat Dis. 2011;7:575-580.
57. Kehagias I,Karamanakos SN,Argentou M,Kalfarentzos F.Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the management of patients with BMI < 50 kg/m2.Obes Surg. 2011;21:1650-1656.
58. Lakdawala MA,Muda NH,Goel S,Bhasker A.Single-incision sleeve gastrectomy versus conventional laparoscopic sleeve gastrectomy: a randomised pilot study.Obes Surg. 2011;21:1664-1670.
59. Martins C,Strommen M,Stavne OA,Nossum R,Marvik R,Kulseng B.Bariatric surgery versus lifestyle interventions for morbid obesity: changes in body weight, risk factors and comorbidities at 1 year.Obes Surg. 2011;21:841-849.
60. Sovik TT,Aasheim ET,Taha O,et al.Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial.Ann Intern Med. 2011;155:281-291.
61. Mukherjee S,Devalia K,Rahman MG,Mannur KR.Sleeve gastrectomy as a bridge to a second bariatric procedure in superobese patients: a single institution experience.Surg Obes Relat Dis. 2012;8:140-144.
62. Nelson DW,Blair KS,Martin MJ.Analysis of obesity-related outcomes and bariatric failure rates with the duodenal switch vs gastric bypass for morbid obesity.Arch Surg. 2012;147:847-854.
63. Prasad P,Tantia O,Patle N,Khanna S,Sen B.An analysis of 1-3-year follow-up results of laparoscopic sleeve gastrectomy: an Indian perspective.Obes Surg. 2012;22:507-514.
64. Praveen Raj P,Kumaravel R,Chandramaliteeswaran C,Rajpandian S,Palanivelu C.Is laparoscopic duodenojejunal bypass with sleeve an effective alternative to Roux en Y gastric bypass in morbidly obese patients: preliminary results of a randomized trial.Obes Surg. 2012;22:422-426.
65. Saul D,Stephens D,Hofstatter Rde C,Ahmed L,Langhoff E,Heimann TM.Preliminary outcomes of laparoscopic sleeve gastrectomy in a Veterans Affairs medical center.Am J Surg. 2012;204:e1-e6.
66. Ikramuddin S,Korner J,Lee WJ,et al.Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.JAMA. 2013;309:2240-2249.
67. Pata G,Crea N,Di Betta E,Bruni O,Vassallo C,Mittempergher F.Biliopancreatic diversion with transient gastroplasty and duodenal switch: long-term results of a multicentric study.Surgery. 2013;153:413-422.
68. Jensen MD,Ryan DH,Apovian CM,et al.2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society.Circulation:.
69. Vest AR,Heneghan HM,Agarwal S,Schauer PR,Young JB.Bariatric surgery and cardiovascular outcomes: a systematic review.Heart. 2012;98:1763-1777.